|
DPH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.476400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.406360E-01 |
| Normal-vs-Stage2 |
8.877000E-01 |
| Normal-vs-Stage3 |
5.903400E-03 |
| Normal-vs-Stage4 |
2.945400E-01 |
| Stage1-vs-Stage2 |
3.238000E-01 |
| Stage1-vs-Stage3 |
3.395800E-02 |
| Stage1-vs-Stage4 |
8.523200E-01 |
| Stage2-vs-Stage3 |
2.558100E-02 |
| Stage2-vs-Stage4 |
4.274400E-01 |
| Stage3-vs-Stage4 |
3.055600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.112200E-02 |
| Normal-vs-AfricanAmerican |
4.780400E-01 |
| Normal-vs-Asian |
5.726200E-01 |
| Caucasian-vs-AfricanAmerican |
7.422200E-01 |
| Caucasian-vs-Asian |
4.784500E-02 |
| AfricanAmerican-vs-Asian |
3.117600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.377200E-01 |
| Normal-vs-Female |
5.156100E-02 |
| Male-vs-Female |
5.419800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.763230E-01 |
| Normal-vs-Age(41-60Yrs) |
1.006820E-01 |
| Normal-vs-Age(61-80Yrs) |
2.100600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.491020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.132200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.700000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.143800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.814000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.142600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.996000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.63609999998182E-06 |
| Classical-VS-Follicular |
2.642200E-01 |
| Classical-VS-Other |
9.057200E-01 |
| Classical-VS-Normal |
3.328600E-01 |
| Tall-VS-Follicular |
4.122300E-03 |
| Tall-VS-Other |
3.730000E-02 |
| Tall-VS-Normal |
1.74450000000048E-05 |
| Follicular-VS-Other |
7.981800E-01 |
| Follicular-VS-Normal |
1.014250E-01 |
| Other-VS-Normal |
5.983200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.057000E-01 |
| Normal-vs-N1 |
6.831000E-01 |
| N0-vs-N1 |
5.602600E-01 |
|
|
